Schrödinger, Inc.

Supplier

www.schrodinger.com

Summarized by Halo AI

Schrödinger, Inc. provides a physics-based and AI-powered computational platform that enables researchers in the pharmaceutical, biotechnology, and materials science industries to accelerate the discovery and design of novel molecules.

Revenue

~$255.9M (2025)

Portfolio summary

Computational software platform for molecular discovery and materials design, enterprise informatics solutions including LiveDesign and Maestro, and a pipeline of collaborative and proprietary drug discovery programs.

Markets served

NA · EMEA · APAC

Schrödinger is a publicly traded software company (NASDAQ: SDGR) specializing in computational chemistry. Founded in 1990, it has grown to become the gold standard for many in silico drug design tasks. Beyond software, it also runs internal drug discovery programs, sometimes in joint ventures (e.g., with Nimbus Therapeutics) to prove out its tech.

AI summary generated on Jun 22, 2026

OpenAlex

For general inquiries

Shelby Stavretis

Business Development

Is this page yours? Boost its visibility

List technologies, facilities, services, or grant collaboration opportunities.

Schrödinger, Inc.

For general inquiries

Key links